Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
07/2008
07/09/2008CN101218222A Vanillin acetals and sensory stimulant composition containing the same
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400495C Process for the preparation of alkanediol
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008CA2373974C Treatment of a composition comprising a trimethylolalkane bis-monolinear formal
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
07/03/2008US20080161391 Novel curcumin analogues and uses thereof
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure
07/03/2008CA2664118A1 Protease inhibitors
07/02/2008EP1938819A2 Use of specific cyclolignans
07/02/2008EP1938818A2 Use of specific cyclolignans
07/02/2008EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
07/02/2008EP1633702B1 Protease inhibitors
07/02/2008CN101213173A Process for production of optically active aminopentane derivative, intermediate and process for producing the intermediate
07/02/2008CN101210006A Method for preparing vinylene carbonate
07/02/2008CN101210005A Method for preparing fluoroethylene carbonate
07/01/2008US7393962 preparation of alkoxycarbonylmethoxy cyclopentanes which are useful intermediates in the preparation of pharmaceutically active triazolo[4,5-d]pyrimidine cyclopentanes
06/2008
06/26/2008WO2008075545A1 Fluorine-containing compound and fluorine-containing polymer
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008074693A2 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
06/26/2008US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/26/2008CA2671856A1 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/25/2008EP1935879A1 Substituted cycloalkene derivative
06/25/2008EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
06/25/2008EP0915699A4 Stereoselective synthesis of endothelin receptor antagonists
06/25/2008CN101208320A N-hydroxyamide derivatives and use thereof
06/25/2008CN101205226A Method for preparing monochlorin ethylene carbonate ester and vinylene carbonate
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/19/2008US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
06/19/2008US20080146580 Anititumoral Ecteinascidin Derivatives
06/19/2008US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy
06/18/2008EP1931650A1 Method for the production of dioxolane
06/18/2008EP1931347A2 Piperazine derivatives
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/18/2008CN101203502A ( 6-flu0r0-benz0[l, 3] dioxolyl) -morpholin-4-yl-methanones and their use as cbl ligands
06/18/2008CN101203500A Substituted arylamine compounds and uses as 5-HT6 moderator thereof
06/18/2008CN101200461A Method for preparing high-purity chloro-cyclic carbonates
06/17/2008CA2286772C Fungicide active substance combinations
06/17/2008CA2284468C Anti-inflammatory compounds
06/12/2008WO2008068423A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
06/12/2008WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols
06/12/2008US20080139826 Method For Manufacturing Fullerene Derivatives
06/12/2008US20080139825 Process For Producing Optically Active Beta-Hydroxy-Alpha-Aminocarboxylic Acid Derivative
06/12/2008US20080139519 Applying moist heat to a suspension of a labile glucocorticosteroid, in particular, budesonide or beclomethasone dipropionate, for a sterilizing-effective time; for preventing, reversing, and/or reducing symptoms of allergic and/or inflammatory conditions
06/12/2008US20080138536 Sprayable Coating Compositions
06/12/2008CA2671179A1 Biphenyl-substituted spirocyclic ketoenols
06/12/2008CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy
06/11/2008CN101195610A Method for purifying vinylene carbonate
06/11/2008CN100393711C Process for producing an alkylene carbonate
06/10/2008US7385067 Process for the preparation of compounds having a CF2O bridge
06/05/2008WO2008064827A2 Process for preparing nebivolol
06/05/2008CA2835833A1 Process for preparing nebivolol
06/05/2008CA2667919A1 Process for preparing nebivolol
06/04/2008EP1193250B1 Phenyl sulfamate derivatives
06/03/2008US7381828 Forming a salt such as a tartrate or mandelate of 6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy}-1-ethanol, chemical intermediates
06/03/2008US7381734 Serine protease inhibitors
06/03/2008CA2389360C Urea derivatives as anti-inflammatory agents
06/03/2008CA2322372C 4-methylene-1,3-dioxolanes having functional groups
05/2008
05/29/2008WO2008061871A1 Ketomethionine ketals and their derivatives
05/29/2008WO2008061308A1 Protein tyrosine phosphatase modulators
05/29/2008US20080125483 3-Aminomethyl-5-methyl-hexanoic acid 1-ethyloxycarbonyloxy-ethyl ester; epilepsy, depression, anxiety, psychosis, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, panic, pain
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008CA2669893A1 Ketomethionine ketals and their derivatives
05/28/2008EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
05/28/2008CN101189318A Reversibly thermochromic compositions
05/28/2008CN101186602A Method for synthesizing 2-methyl-2-aryl-1,3-dioxolane compound
05/28/2008CN100390167C Total synthesis of myriaporones
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/28/2008CN100390134C Compositions for treating acne comprising phytandiol amine
05/27/2008US7378548 Michael addition of an acrylic acid ester to a secondary amine such as diethanolamine; additives in chemical amplification photolithography giving photoresists with high resolution and excellent focus margin
05/22/2008WO2008059841A1 Process for production of 1-acyloxy-3-(3,4- methylenedioxyphenyl)-1-propene compound
05/22/2008WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
05/22/2008US20080119547 Treating of a psychological disorder by administering a 3-Benzo[1,3]dioxol-5-yl-indan-1-yl)-dimethylamine or analogous 1,3-dithio, 1-oxa-3-thio ring derivatives; antidepressants; anxiolytic agents; post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, phobias
05/22/2008US20080119528 use of specific cyklolignans
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/20/2008US7375224 adenine modified solid, ordered, mesoporous, bifunctional, organo-inorganic silica-based catalyst; to obtain the desired product of cyclic carbonate
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008CA2395717C Fused imidazolium derivatives
05/15/2008US20080114061 Diphenylethylene compounds and uses thereof
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008US20080112899 Carboxamides and Their Use
05/14/2008EP1921062A2 Amino acid derivatives as HIV aspartyl protease inhibitors
05/14/2008EP1919854A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
05/14/2008CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
05/13/2008US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action
05/13/2008US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties
05/13/2008CA2263348C Pharmaceutical composition containing 4-oxo-butynic acids
05/07/2008EP1569923B1 Use of a mixture of esters of fatty acids as fuel or solvent
05/07/2008EP1344109B1 Onium salts and the use therof as latent acids
05/07/2008CN101175745A Method for producing 4,4'-bicyclohexanedione monoketal
05/07/2008CN101175744A Method of storing and transporting vinylene carbonate
05/07/2008CN101175743A High-purity vinylene carbonate and a method of purifying vinylene carbonate
05/07/2008CN101175742A Process for producing vinylene carbonate
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 183